Jose Luis Cabriada
Overview
Explore the profile of Jose Luis Cabriada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez-Lago I, Aguirre U, Cabriada J, Ungaro R, Colombel J, Barreiro-de Acosta M
Am J Gastroenterol
. 2025 Jan;
PMID: 39787350
This study investigates whether subclinical inflammation in asymptomatic patients with inflammatory bowel disease (IBD) leads to increased medication use. In a multicenter, retrospective analysis of patients diagnosed with incidental ulcerative...
2.
Ferreiro-Iglesias R, Porto Silva S, Marin S, Casanova M, Manosa M, Gonzalez-Munoza C, et al.
Aliment Pharmacol Ther
. 2024 Jun;
60(5):604-612.
PMID: 38943230
Background: Ulcerative proctitis (UP) can have a milder, less aggressive course than left-sided colitis or extensive colitis. Therefore, immunosuppressants tend to be used less in patients with this condition. Evidence,...
3.
Rodriguez-Lago I, Aduna M, De la Piscina P, Merino O, Carrascosa J, Higuera R, et al.
Int J Colorectal Dis
. 2024 Jun;
39(1):92.
PMID: 38871954
Purpose: Crohn's disease (CD) is a progressive disorder leading to cumulative bowel damage. The Lémann index is a validated tool that can help in monitoring the progression of the disease...
4.
Gomez-Labrador C, Ricart E, Iborra M, Iglesias E, Martin-Arranz M, De Castro L, et al.
Pharmaceutics
. 2024 May;
16(5).
PMID: 38794292
Markers that allow for the selection of tailored treatments for individual patients with inflammatory bowel diseases (IBD) are yet to be identified. Our aim was to describe trends in real-life...
5.
Rodriguez-Lago I, Herrera-deGuise C, Bosca-Watts M, Rodriguez C, Leo-Carnerero E, Calvo Iniguez M, et al.
Gastroenterol Hepatol
. 2024 May;
47(10):502195.
PMID: 38710466
Objective: Granulocyte-monocyte apheresis (GMA) has shown to be safe and effective in ulcerative colitis (UC), also in combination with biologics, mainly with anti-TNF. The aim of this study was to...
6.
Rodriguez-Lago I, Cabriada J, Rodriguez A, Barreiro-de Acosta M
Crohns Colitis 360
. 2024 Mar;
6(1):otae018.
PMID: 38544908
Background: The immune dysregulation underlying inflammatory bowel disease (IBD) can start years before the diagnosis, but the role of triggering factors and environmental exposures during this period is still uncertain....
7.
Rodriguez-Lago I, Canete F, Guerra-Del-Rio E, Herrera-deGuise C, Iglesias E, Leo E, et al.
Gastroenterol Hepatol
. 2024 Jan;
47(7):727-733.
PMID: 38266817
Objective: Granulocyte-monocyte apheresis (GMA) has shown to be safe and effective in treating ulcerative colitis (UC), also in combination with biologics. The objective of this study is to evaluate the...
8.
Rodriguez-Lago I, Abecia L, Seoane I, Anguita J, Cabriada J
Gastroenterol Hepatol
. 2023 Jul;
47(4):347-351.
PMID: 37422185
Objective: Primary non-response and secondary loss of response to anti-TNF agents are common in inflammatory bowel disease. Increasing drug concentrations are correlated to better clinical response and remission rates. Combination...
9.
Zabana Y, Marin-Jimenez I, Rodriguez-Lago I, Vera I, Martin-Arranz M, Guerra I, et al.
J Clin Med
. 2022 Dec;
11(24).
PMID: 36556155
(1) Scant information is available concerning the characteristics that may favour the acquisition of COVID-19 in patients with inflammatory bowel disease (IBD). Therefore, the aim of this study was to...
10.
Rodriguez-Lago I, Aguirre U, De la Piscina P, Munagorri A, Zapata E, Higuera R, et al.
United European Gastroenterol J
. 2022 Dec;
11(1):9-18.
PMID: 36547009
Background: Previous data support that the inflammatory process underlying ulcerative colitis (UC) and Crohn's disease (CD) can start years before the diagnosis. The aim of this study was to determine...